Exomic sequencing of the glutamate receptor, ionotropic, N-methyl-d-aspartate 3A gene (GRIN3A) reveals no association with schizophrenia

Schizophrenia Research

Volumn 114, Issue 1-3, 2009, Pages 25-32

  Shen, Yu Chih ^a,b   Liao, Ding Lieh ^c,d   Chen, Jen Yeu ^e   Wang, Ying Chieh ^e   Lai, I Ching ^e   Liou, Ying Jay ^f   Chen, Yu Jun ^g   Luu, Sy Ueng ^h   Chen, Chia Hsiang ^a,d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c Bali Psychiatric Center   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e YULI VETERANS HOSPITAL   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^h Armed Force Taoyuan General Hospital   (Taiwan)

Author keywords

GRIN3A; NMDAR; NR3A; Pathogenesis; Rare mutations; Schizophrenia

Indexed keywords

GLUTAMATE RECEPTOR IONOTROPIC N METHYL DEXTRO ASPARTATE 3A PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, AMPA; SCHIZOPHRENIA; TAIWAN;

EID: 69949135312     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.07.005     Document Type: Article

References (59)

1. Andersson O., Stenqvist A., Attersand A., and von Euler G. Nucleotide sequence, genomic organization, and chromosomal localization of genes encoding the human NMDA receptor subunits NR3A and NR3B. Genomics 78 (2001) 178-184
2. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
3. Bendel O., Meijer B., Hurd Y., and von Euler G. Cloning and expression of the human NMDA receptor subunit NR3B in the adult human hippocampus. Neurosci. Lett. 377 (2005) 31-36
4. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., and Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 15 (1995) 6498-6508
5. Craddock N., O'Donovan M.C., and Owen M.J. Phenotypic and genetic complexity of psychosis. Invited commentary on... Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 200-203
6. Cull-Candy S., Brickley S., and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11 (2001) 327-335
7. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393 (1998) 377-381
8. Di Maria E., Gulli R., Begni S., De Luca A., Bignotti S., Pasini A., et al. Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 128B (2004) 27-29
9. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12 (2003) 205-216
10. Eriksson M., Nilsson A., Froelich-Fabre S., Akesson E., Dunker J., Seiger A., et al. Cloning and expression of the human N-methyl-d-aspartate receptor subunit NR3A. Neurosci. Lett. 321 (2002) 177-181
11. Eriksson M., Nilsson A., Samuelsson H., Samuelsson E.B., Mo L., Akesson E., et al. On the role of NR3A in human NMDA receptors. Physiol. Behav. 92 (2007) 54-59
12. Faul F., Erdfelder E., Lang A.G., and Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39 (2007) 175-191
13. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
14. Galehdari H., Pooryasin A., Foroughmand A., Daneshmand S., and Saadat M. Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. J. Mol. Neurosci. 37 (2009) 95
15. Gallinat J., Gotz T., Kalus P., Bajbouj M., Sander T., and Winterer G. Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J. Cogn. Neurosci. 19 (2007) 59-68
16. Gulli R., Masnata B., Bonvicini C., Tura G.B., Manglaviti L., Vaggi M., et al. A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. Psychiatr. Genet. 17 (2007) 355-356
17. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
18. Henson M.A., Roberts A.C., Salimi K., Vadlamudi S., Hamer R.M., Gilmore J.H., et al. Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb. Cortex 18 (2008) 2560-2573
19. Hung C.C., Chen H.Y., and Chen C.H. Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-d-aspartate 1 gene (GRIN1) in schizophrenic patients. Psychiatr. Genet. 12 (2002) 225-230
20. Iwayama-Shigeno Y., Yamada K., Itokawa M., Toyota T., Meerabux J.M., Minabe Y., et al. Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia. Neurosci. Lett. 378 (2005) 102-105
21. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 78 (2007) 69-108
22. Javitt D.C. Glycine transport inhibitors and the treatment of schizophrenia. Biol. Psychiatry 63 (2008) 6-8
23. Kristiansen L.V., Huerta I., Beneyto M., and Meador-Woodruff J.H. NMDA receptors and schizophrenia. Curr. Opin. Pharmacol. 7 (2007) 48-55
24. Lang U.E., Puls I., Muller D.J., Strutz-Seebohm N., and Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol. Biochem. 20 (2007) 687-702
25. Lau C.G., and Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8 (2007) 413-426
26. Lee T.H., Yi W., Griswold M.D., Zhu F., and Her C. Formation of hMSH4-hMSH5 heterocomplex is a prerequisite for subsequent GPS2 recruitment. DNA Repair. (Amst) 5 (2006) 32-42
27. Li D., and He L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet. Med. 9 (2007) 4-8
28. Makino C., Shibata H., Ninomiya H., Tashiro N., and Fukumaki Y. Identification of single-nucleotide polymorphisms in the human N-methyl-d-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia. Psychiatr. Genet. 15 (2005) 215-221
29. Martucci L., Wong A.H., Trakalo J., Cate-Carter T., Wong G.W., Macciardi F.M., et al. N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am. J. Med. Genet. B Neuropsychiatr. Genet. 119B (2003) 24-27
30. Martucci L., Wong A.H., De Luca V., Likhodi O., Wong G.W., King N., et al. N-methyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels. Schizophr. Res. 84 (2006) 214-221
31. Matsuda K., Kamiya Y., Matsuda S., and Yuzaki M. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain Res. Mol. Brain Res. 100 (2002) 43-52
32. McClellan J.M., Susser E., and King M.C. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 194-199
33. Mueller H.T., and Meador-Woodruff J.H. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr. Res. 71 (2004) 361-370
34. Nilsson A., Eriksson M., Muly E.C., Akesson E., Samuelsson E.B., Bogdanovic N., et al. Analysis of NR3A receptor subunits in human native NMDA receptors. Brain Res. 1186 (2007) 102-112
35. Ohtsuki T., Sakurai K., Dou H., Toru M., Yamakawa-Kobayashi K., and Arinami T. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol. Psychiatry 6 (2001) 211-216
36. Paoletti P., and Neyton J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 7 (2007) 39-47
37. Parmley J.L., and Hurst L.D. How do synonymous mutations affect fitness?. Bioessays 29 (2007) 515-519
38. Paus S., Rietschel M., Schulze T.G., Ohlraun S., Diaconu C.C., Van Den Bogaert A., et al. Systematic screening for mutations in the human N-methyl-d-aspartate receptor 1 gene in schizophrenic patients from the German population. Psychiatr. Genet. 14 (2004) 233-234
39. Peng Y.-C., Kuo F., Breiding D.E., Wang Y.-F., Mansur C.P., and Androphy E.J. AMF1 (GPS2) modulates p53 transactivation. Mol. Cell Biol. 21 (2001) 5913-5924
40. Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S., Sucher N.J., et al. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J. Neurosci. 21 (2001) 1228-1237
41. Qin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., et al. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur. J. Hum. Genet. 13 (2005) 807-814
42. Rice S.R., Niu N., Berman D.B., Heston L.L., and Sobell J.L. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol. Psychiatry 6 (2001) 274-284
43. Sanyal S., Båvner A., Haroniti A., Nilsson L.M., Lundåsen T., Rehnmark S., et al. Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15665-15670
44. Sauna Z.E., Kimchi-Sarfaty C., Ambudkar S.V., and Gottesman M.M. The sounds of silence: synonymous mutations affect function. Pharmacogenomics 8 (2007) 527-532
45. Schüler T., Mesic I., Madry C., Bartholomäus I., and Laube B. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-d-aspartate receptor assembly. J. Biol. Chem. 283 (2008) 37-46
46. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
47. Shim S.S., Hammonds M.D., and Kee B.S. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur. Arch. Psychiatry Clin. Neurosci. 258 (2008) 16-27
48. Stahl S.M. The genetics of schizophrenia converge upon the NMDA glutamate receptor. CNS Spectr. 12 (2007) 583-588
49. Tandon R., Keshavan M.S., and Nasrallah H.A. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res. 102 (2008) 1-18
50. Tang J., Chen X., Xu X., Wu R., Zhao J., Hu Z., et al. Significant linkage and association between a functional (GT)n polymorphism in promoter of the N-methyl-d-aspartate receptor subunit gene (GRIN2A) and schizophrenia. Neurosci. Lett. 409 (2006) 80-82
51. Tsai C.J., Sauna Z.E., Kimchi-Sarfaty C., Ambudkar S.V., Gottesman M.M., and Nussinov R. Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J. Mol. Biol. 383 (2008) 281-191
52. Ulbrich M.H., and Isacoff E.Y. Rules of engagement for NMDA receptor subunits. Proc. Natl. Acad. Sci. USA. 105 (2008) 14163-14168
53. van Os J., Rutten B.P., and Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull. 34 (2008) 1066-1082
54. Wee K.S., Zhang Y., Khanna S., and Low C.M. Immunolocalization of NMDA receptor subunit NR3B in selected structures in the rat forebrain, cerebellum, and lumbar spinal cord. J. Comp. Neurol. 509 (2008) 118-135
55. Yao Y., and Mayer M.L. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. J. Neurosci. 26 (2006) 4559-4566
56. Yao Y., Harrison C.B., Freddolino P.L., Schulten K., and Mayer M.L. Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors. EMBO J. 27 (2008) 2158-2170
57. Zhang J., Kalkum M., Chait B.T., and Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9 (2002) 611-623
58. Zhang D., Harry G.J., Blackshear P.J., and Zeldin D.C. G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator. J. Biol. Chem. 283 (2008) 8580-8590
59. Zhao X., Li H., Shi Y., Tang R., Chen W., Liu J., et al. Significant association between the genetic variations in the 5′ end of the N-methyl-d-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol. Psychiatry 59 (2006) 747-753